Key to acute myeloid leukaemia could be ‘sleeping stem cells’

Jul 31st, 2013 · Comments Off

Main Category: Lymphoma / Leukemia / Myeloma
Also Included In: Stem Cell Research
Article Date: 31 Jul 2013 – 0:00 PDT

Mary, Queen. “Key to acute myeloid leukaemia could be ‘sleeping stem cells’.” Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
31 Jul. 2013. <http://www.medicalnewstoday.com/releases/264104.php>



Queen Mary, University of London

Dr David Taussig, from the Barts Cancer Institute at Queen Mary, University of London, who led the research, said: “The widely accepted explanation has held that AML causes bone marrow failure by depleting the bone marrow of normal haematopoietic stem cells by killing or displacing them.

The findings were confirmed by the analysis of bone marrow from 16 patients with AML.

Scientists studying an aggressive form of leukaemia have discovered that rather than displacing healthy stem cells in the bone marrow as previously believed, the cancer is putting them to sleep to prevent them forming new blood cells.

The scientists studied the levels of haematopoietic stem cells (HSC) in the bone marrow of mice transplanted with human AML. They found the numbers of normal mouse HSCs stayed the same, however what did change was that the HSCs were no longer going through the stages of development which finally results in the formation of new blood cells.

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

‘Acute myeloid leukaemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation’, by Miraki-Moud et al. is published today in the Proceedings of the National Academy of Sciences (PNAS).

Normally, the bone marrow produces haematopoietic stem cells which mature into “adult” blood cells. In people with AML the bone marrow is invaded by leukaemic myeloid cells which aren’t able to develop into normal functioning blood cells.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

The finding offers the potential that these stem cells could somehow be turned back on, offering a new form of treatment for the condition, called Acute Myeloid Leukaemia (AML). The work was led by scientists at Queen Mary, University of London with the support of Cancer Research UK’s London Research Institute.

Please note: If no author information is provided, the source is cited instead.

Contact Our News Editors

lymphoma / leukemia / myeloma section for the latest news on this subject.

“However, we have found that samples of bone marrow in both mice models and patients with AML contain the same, or more, of these normal stem cells than usual. So the cancer isn’t getting rid of them, instead it appears to be turning them off so they aren’t going on to form healthy blood cells.

The result is that the body does not have enough red blood cells or platelet cells, which can cause symptoms of anaemia, such as tiredness, and increase the risk of excessive bleeding. Patients are also more vulnerable to infection as the white blood cells, which fight bacteria and viruses, are not properly formed.

The findings are published today in the journal the Proceedings of the National Academy of Sciences (PNAS).

Current ratings for:
Key to acute myeloid leukaemia could be ‘sleeping stem cells’

Please use one of the following formats to cite this article in your essay, paper or report:

Dr Taussig added: “Usually when the body is stressed, the stem cells become very active. For example, if you have a haemorrhage, they will jump into action to produce more new blood cells. The cancer cells are somehow over-riding this and our next phase of work will concentrate on how they are doing this.”

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

APA

Professor Peter Johnson, Cancer Research UK’s chief clinician, said: “Although major progress has been made in treating AML over the years, there’s still an urgent need for more effective treatments to improve long-term survival. This study takes us an important step forwards in our understanding of what’s going on in the bone marrow of people with AML, an area that we have not known enough about previously, and the challenge now is to turn this understanding into new treatments for patients.”


privacy policy for more information.

“If we can find out how the cancer cells are doing this, we can look at exploiting it to find ways to wake these stem cells up. This is very important as, while the cure rate for younger patients can be around 40 per cent, in older patients it is much lower. The treatments we have, such as chemotherapy and bone marrow transplants, just aren’t very successful in this older patient group.”

If you write about specific medications or operations, please do not name health care professionals by name.

Around 2,500* people are diagnosed with AML in the UK each year, both young and old. Although AML is curable in some the majority die from this disease.

MLA


*Figures from Cancer Research UK


Share this post:

If you are a possible stem cell patient, find ways to get a stem cell cure to have much better health and youthfulness

If you're a medical doctor and would like to learn and incorporate various stem cell treatments into your medical practice, be sure to get the proper stem cell medical training


Recent Posts

© 2023 Get Stem Cell Treatments. All rights reserved.

WordPress Theme by Theme Junkie